Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework. - Shemesh CS; Chan P; Marchand M; Gonçalves A; Vadhavkar S; Wu B; Li C; Jin JY; Hack SP; Bruno R (Clinical pharmacology and therapeutics, 2023)